pyrazolanthrone has been researched along with hesperadin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Backes, BJ; Feldman, HC; Gliedt, MJ; Gobillot, TA; Hari, SB; Lebedev, I; Maly, DJ; Meza-Acevedo, R; Mitra, AK; Papa, FR; Seeliger, MA; Tong, M; Wang, L | 1 |
| Mackey, ZB; Ramsey, AC; Santos, WL; Valenciano, AL | 1 |
2 other study(ies) available for pyrazolanthrone and hesperadin
| Article | Year |
|---|---|
Structural and Functional Analysis of the Allosteric Inhibition of IRE1α with ATP-Competitive Ligands.
Topics: Adenosine Triphosphate; Allosteric Regulation; Binding, Competitive; Endoplasmic Reticulum Stress; Endoribonucleases; Humans; Ligands; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Ribonucleases; Structure-Activity Relationship | 2016 |
Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor.
Topics: Aminopyridines; Drug Discovery; Extracellular Signal-Regulated MAP Kinases; Humans; Protein Kinase Inhibitors; Pyrazoles; Recombinant Proteins; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2016 |